Version 4 · Coming Soon

PREDICT v4 is on its way.

We are building a new and more powerful version of PREDICT — the online tool that helps patients and clinicians see how different treatments for early invasive breast cancer might improve survival rates.

PREDICT v4 will draw on expanded data from a large, diverse, contemporary US population; updated treatment evidence and guidelines; and improved modelling, including incorporation of Oncotype DX scores, to provide clearer and more personalized estimates.

In the meantime, please continue to use PREDICT v3.

Get notified when v4 launches:

One email when v4 launches. No spam, ever.

Did you mean to visit Predict Prostate?

Updated survival data

Trained on a significantly larger, more recent patient cohort, reflecting contemporary outcomes from modern NHS breast cancer care.

New treatment options

Incorporates contemporary chemotherapy regimens, targeted therapies, and immunotherapy outcomes so clinicians can counsel patients more fully.

Wider equity reach

Validated across diverse patient populations to ensure fair and accurate predictions for all, with improved plain-language outputs.

University of Cambridge – Winton Centre for Risk and Evidence Communication